Skip to content

METTL3-mediated N6-methyladenosine modification of circHUWE1 promotes high glucose-induced cardiomyocyte apoptosis and ferroptosis-related alterations through regulating miR-671-5p/CELF1 axis

Jul 2026 · Molecular and Cellular Biochemistry · Vol 481, pp. 4029 - 4041 · 0 citations · 47 references
Medicine

TL;DR

The circHUWE1/miR-671-5p/CELF1 axis regulates HG-induced cardiomyocyte apoptosis and ferroptosis-related alterations and represents a novel mechanism underlying Dex-mediated cardioprotection.

View source

Similar papers

Open access Aug 2026

LncRNA GAS6-AS1 affects doxorubicin‑induced cardiomyocyte injury in H9c2 cells by regulating miR‑152‑3p: a cellular model relevant to heart failure

Overexpression of GAS6-AS1 could mitigate the reduction in cell viability and the elevation in apoptosis induced by DOX in H9c2 cells, and inhibit the expression of pro-inflammatory factors.

Mi Li, Ning Lu, Lu-Xi Yang et al. · 0 citations
Open access 2026

Regulatory role of the circHIPK3/miR-125a-5p/NDUFA5 axis in diabetic retinopathy: combined analysis of single-cell and bulk transcriptomes.

OBJECTIVE To explore the expression localization, functional effects, and upstream regulatory mechanism mediated by circHIPK3 (homeodomain interacting protein kinase 3)/miR-125a-5p of NDUFA5 (NADH-ubiquinone oxidoreductase 1 alpha subcomplex 5) in diabetic retinopathy (DR) by integrating public single-cell and bulk RNA...

Zhi-Hui Zhang, Yuan-Feng Liu, Mei Bai · 0 citations
Open access Jul 2026

Nuclear m6A Methylase METTL3 Drives Production of ITGβ4E to Exacerbate Heart Failure via SRSF3-Mediated Alternative Splicing of ITGβ4.

The m6A methylase METTL3 drives production of ITGβ4E to exacerbate HF via SRSF3-mediated alternative splicing of ITGβ4 mRNA, suggesting that alternative splicing of ITGβ4 may be a potential therapeutic target for HF.

Li Yao, Chao Liu, Jian Dong et al. · 0 citations
Open access Sep 2026

lncRNA Gm10451 mediates β-cell functional impairment in type 1 diabetes through the miR-24-3p/G6PD axis

Overexpression of Gm10451 suppressed G6PD, aggravated oxidative/ER stress and inflammation, inhibited insulin secretion and promoted β-cell apoptosis, representing a poteniall therapeutic target for diabetes-related β-cell dysfunction.

Jiao Wang, Li-Hai Zhang, Xian-He Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.